We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTAB Won’t Sanction Hedge Fund Owner Over Inter Partes Reviews
PTAB Won’t Sanction Hedge Fund Owner Over Inter Partes Reviews
The U.S. Patent and Trademark Office has denied Celgene’s request to sanction a hedge fund owner for seeking to profit by challenging the validity of drug patents, saying there was nothing inherently wrong with the action.